The aim of this systematic review was to answer the question: What are the treatments
available for bisphosphonate-related osteonecrosis of the jaws (BRONJ) and their …

Objectives: The clinical management of bisphosphonate-related osteonecrosis of the jaw
(BRONJ) remains controversial. Since universally accepted guidelines have not been …

The aim was to evaluate the knowledge about bisphosphonate-related osteonecrosis of the
jaws (BRONJ). A bibliographic search in Medline, PubMed and the Cochrane Register of …

J Oral Pathol Med (2012) 41: 214–221 The osteonecrosis of the jaws (ONJ) is an adverse
side effect of long‐term bisphosphonate therapy (BPT) firstly described in 2003. The …

Oral Diseases (2012) 18, 625–632 Non‐exposed bisphosphonate‐related osteonecrosis of
the jaw (BRONJ) is a newly reported complication arising from bisphosphonate therapy that …

OBJECTIVES: The aim of this study was to evaluate the 2-year success rate of management
of patients with bisphosphonate-related osteonecrosis of the jaws (BRONJ). STUDY …

PURPOSE: The aim of this study was to evaluate the results of the surgical treatment of
bisphosphonate-related osteonecrosis of the jaw (BRONJ) in a large cohort. MATERIALS …

Background. Osteonecrosis of the jaws occurs after the administration of bisphosphonates.
An unequivocal treatment strategy is yet to be devised. We assess the treatment of patients …

PURPOSE: To report the clinical features, risk factors, management, and treatment
outcomes of nitrogen-containing bisphosphonate (n-BIS)-related osteonecrosis of the jaw …

Background Bisphosphonate drugs can be used to prevent and treat osteoporosis and to
reduce symptoms and complications of metastatic bone disease; however, they are …